Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Unigen Pharmaceuticals Partners with the National Cancer Institute and the Ford Cancer Center to Discover Anti-Solid Tumor Pharmaceutical Drugs
- Unigen Pharmaceuticals Partners with the National Cancer Institute and the Ford Cancer Center to Discover Anti-Solid Tumor Pharmaceutical Drugs
- Unigen Pharmaceuticals Partners with the National Cancer Institute and the Ford Cancer Center to Discover Anti-Solid Tumor Pharmaceutical Drugs
- Complementary Prostate Cancer Therapies To Be Discussed at Calif. State Oriental Medical Assoc. Expo
Integrative approaches to counteracting the side-effects of cancer through dietary supplements, herbal formulas and acupuncture will be presented by Isaac Eliaz, M.D., M.S.C., L.Ac.
- Complementary Prostate Cancer Therapies To Be Discussed at Calif. State Oriental Medical Assoc. Expo
Integrative approaches to counteracting the side-effects of cancer through dietary supplements, herbal formulas and acupuncture will be presented by Isaac Eliaz, M.D., M.S.C., L.Ac.
- Complementary Prostate Cancer Therapies To Be Discussed at Calif. State Oriental Medical Assoc. Expo
Integrative approaches to counteracting the side-effects of cancer through dietary supplements, herbal formulas and acupuncture will be presented by Isaac Eliaz, M.D., M.S.C., L.Ac.
- International Cancer Conference Explores New Weapons in the Fight Against Colorectal Cancer
Special symposium held, focused on “IP6 and Cell Signaling in Fighting Cancer: From Laboratory to Clinic.”
- International Cancer Conference Explores New Weapons in the Fight Against Colorectal Cancer
Special symposium held, focused on “IP6 and Cell Signaling in Fighting Cancer: From Laboratory to Clinic.”
- International Cancer Conference Explores New Weapons in the Fight Against Colorectal Cancer
Special symposium held, focused on “IP6 and Cell Signaling in Fighting Cancer: From Laboratory to Clinic.”
- International Cancer Conference Explores New Weapons in the Fight Against Colorectal Cancer
Special symposium held, focused on “IP6 and Cell Signaling in Fighting Cancer: From Laboratory to Clinic.”
- International Cancer Conference Explores New Weapons in the Fight Against Colorectal Cancer
Special symposium held, focused on “IP6 and Cell Signaling in Fighting Cancer: From Laboratory to Clinic.”
- eWorldMedia, Inc. Reaches Agreement in Principle with Natura, Inc. for International Marketing Rights to Cellular Health and Nutrition Line
Company has reached an "Agreement in Principle" with Natura, Inc. to market Natura's product line of cellular health and nutrition products through eWorldMedia's international base of distributors.
- eWorldMedia, Inc. Reaches Agreement in Principle with Natura, Inc. for International Marketing Rights to Cellular Health and Nutrition Line
Company has reached an "Agreement in Principle" with Natura, Inc. to market Natura's product line of cellular health and nutrition products through eWorldMedia's international base of distributors.
- eWorldMedia, Inc. Reaches Agreement in Principle with Natura, Inc. for International Marketing Rights to Cellular Health and Nutrition Line
Company has reached an "Agreement in Principle" with Natura, Inc. to market Natura's product line of cellular health and nutrition products through eWorldMedia's international base of distributors.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
PISCATAWAY, NJ, October 26, 2005 - Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo in Las Vegas, Nev.
Sabinsa has invited Shishir Shishodia, Ph.D., professor at Texas Southern University and researcher at M.D. Anderson Cancer Center, to discuss new research surrounding the role of turmeric-derived curcuminoids in the treatment of certain types of cancers. Curcuminoids are high-powered antioxidants that have been shown to block the chain of events leading to tumor development, progression and expansion. This session will review anti-cancer mechanisms, safety and toxicity and the numerous applications of curcuminoids in the treatment of cancer.
Dr. Shishodia earned his Ph.D. in Biotechnology from Banaras Hindu University (BHU), Varanasi, India, and conducted his postdoctoral fellowship at the University of Texas M. D. Anderson Cancer Center. His research interests include cytokine signaling, the role of transcription factors in tumorigenesis, and regulation of transcription by natural products. Dr.
Shishodia has identified several natural compounds that exhibit anti-cancer properties. He has published more than 50 peer-reviewed papers and edited a book on the role of Resveratrol in health and disease. Dr. Shishodia is also a recipient of the BHU Gold Medal and the Theodore N. Law Award for outstanding scientific achievements.
Curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin are collectively known as curcuminoids, and are recognized as one of the most promising food derived compounds in fighting cancer. Sabinsa Corporation provides an extract of turmeric standardized to 95 percent curcuminoids, Curcumin C3 Complex (R). Over the past several years, numerous studies have been funded by the National Institutes of Health to investigate the role of curcumin and its derivatives in treatment of patients with cancer.
Additionally, M.D. Anderson Cancer Center is involved in pre-clinical and clinical research of the anti-cancer mechanism and application of curcuminoids in conditions including multiple myeloma and colon cancer.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals.
Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 30 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit www.sabinsa.com <http://www.sabinsa.com> or stop by booth #5000 at SupplySide West.
The SupplySide West trade show is dedicated to bringing together manufacturers and suppliers in the dietary supplement, food, pharmaceutical and cosmetic industries. The event provides a unique opportunity for an executive level exchange of ideas, goods and services not available through other any other business-to-business event. SupplySide West offers three days of informative seminars and exhibitions tailored to the specific needs of supply chain executives. For more information visit www.supplysideshow.com/west.
# # #
|